Primary Aim: To determine whether silver-coated transurethral catheter decreases the incidence of culture-confirmed urinary tract infection for women with catheter-managed urinary retention after pelvic reconstructive surgery Secondary Aims: To assess difference in bacterial uropathogens isolated in urine cultures Adverse symptoms possibly caused by silver-coated catheter
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
310
Comparing two types of catheter (silver-coated silicone versus silicone) after Pelvic Reconstructive Surgery (PRS) to compare Urinary Tract Infection (UTI) rates
Cincinnati Urogynecology Associates
Cincinnati, Ohio, United States
Good Samaritan Hospital
Cincinnati, Ohio, United States
Incidence of UTIs requiring treatment
Post-operative UTI rate
Time frame: approximately 4 weeks
Assess the types of bacterial uropathogens isolated from the urine cultures
Time frame: approximately 4 weeks
Adverse symptoms possibly causes by silver-coated catheter
Time frame: approximately 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.